Pfizer (PFE) Debt Ratio (2009 - 2026)

Pfizer (PFE) has 18 years of Debt Ratio data on file, last reported at 0.31 in Q1 2026.

• Quarterly Debt Ratio rose 3.79% year-over-year to 0.31 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.31 (up 3.79% YoY) and the FY2025 annual result came in at 0.31, up 3.88% from the prior year.
• Debt Ratio was little changed at 0.31 in Q1 2026 per PFE's latest filing, from 0.31 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.89 in Q4 2022 and bottomed at 0.18 in Q4 2022.
• The 5-year median for Debt Ratio is 0.3 (2024), against an average of 0.31.
• Peak annual rise in Debt Ratio reached 74.51% in 2023, while the deepest fall reached 66.82% in 2023.
• Tracing PFE's Debt Ratio over 5 years: stood at 0.18 in 2022, then surged by 74.51% to 0.32 in 2023, then retreated by 5.59% to 0.3 in 2024, then climbed by 3.88% to 0.31 in 2025, then declined by 0.45% to 0.31 in 2026.
• Per Business Quant, the three latest PFE Debt Ratio figures stand at 0.31 (Q1 2026), 0.31 (Q4 2025), and 0.3 (Q3 2025).

Peer Comparison